Synectics Regulatory News (SNX)

9 Nov 2005 15:16

Synexus Clinical Research PLC09 November 2005 SYNEXUS CLINICAL RESEARCH PLC09 NOVEMBER 2005 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company SYNEXUS CLINICAL RESEARCH PLC 2. Name of shareholder having a major interest THE ROYAL BANK OF SCOTLAND PLC 3. Please state whether notification indicates that it is in respect of holdingof the shareholder named in 2 above or in respect of a non-beneficial interestor in the case of an individual holder if it is a holding of that person'sspouse or children under the age of 18 AS IN 2 ABOVE 4. Name of the registered holder(s) and, if more than one holder, the number ofshares held by each of them MELLON NOMINEES UK LTD NIFF 3000102 5. Number of shares / amount of stock acquired N/A 6. Percentage of issued class N/A 7. Number of shares / amount of stock disposed N/A 8. Percentage of issued class N/A 9. Class of security ORDINARY GBP0.10 SHARES 10. Date of transaction N/A 11. Date company informed 09 NOVEMBER 2005 12. Total holding following this notification 1,538,461 13. Total percentage holding of issued class following this notification 7.07% 14. Any additional information FIGURES BASED ON SHARES IN ISSUE OF 21,748,251 15. Name of contact and telephone number for queries 16. Name and signature of authorised company official responsible for makingthis notification Date of notification 09 NOVEMBER 2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept any liability for error or omission.The FSA is not liable for any damages (including, without limitation, damagesfor loss of business or loss of profits) arising in contract, tort or otherwisefrom the use of or inability to use this document, or any material contained init, or from any action or decision taken as a result of using this document orany such material. This information is provided by RNS The company news service from the London Stock Exchange